Valuation
- Market cap
- 4,609,000
- Revenue TTM
- $370,000
- Net income TTM
- $-4,300,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -1,162.16%
- Debt to equity
- 0.36
Trading
- Volume
- 13,500
- Avg volume
- 3,627,058
- Day's range
- $0.43 – $0.45
- Shares out
- 10,711,000
- Stochastic %K
- 0%
- Beta
- -0.41
- Analysts
- Strong Buy
- Price target
- —
Company profile
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 61 3 9087 3990
- Website
- https://www.gelteq.com
- Address
- Monash Innovation Labs, G.60, 22 Alliance Lane, Clayton, Australia
Latest news
No headlines yet.
